Guobang Pharma Ltd. (SHA:605507)
China
· Delayed Price · Currency is CNY 26.18
-0.48 (-1.80%)
Mar 9, 2026, 3:00 PM CST
Guobang Pharma Revenue
Guobang Pharma had revenue of 1.44B CNY in the quarter ending September 30, 2025, a decrease of -5.39%. This brings the company's revenue in the last twelve months to 5.94B, up 4.00% year-over-year. In the year 2024, Guobang Pharma had annual revenue of 5.89B with 10.12% growth.
Revenue (ttm)
5.94B
Revenue Growth
+4.00%
P/S Ratio
2.44
Revenue / Employee
1.48M
Employees
4,003
Market Cap
14.48B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Jiuzhou Pharmaceutical | 5.36B |
| Shanghai Shyndec Pharmaceutical | 9.36B |
| ApicHope Pharmaceutical Group | 1.02B |
| Hybio Pharmaceutical | 898.10M |
| Shenzhen Hepalink Pharmaceutical Group | 5.38B |
| Guangdong Zhongsheng Pharmaceutical | 2.45B |
| China Resources Jiangzhong Pharmaceutical Co.,Ltd | 4.24B |
| Nanjing King-Friend Biochemical Pharmaceutical | 3.76B |